ASCs can inhibit the activation of hepatic stellate cells and ultimately treat liver fibrosis by regulating the expression of molecular mediators such as MMP, TIMP1, TGF-β, α-SMA, and COL1A2 [96]. The gene discussed is ACTA1; the disease is Hepatic fibrosis.